These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 8710373

  • 1. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.
    Yao R, Cooper GM.
    Oncogene; 1996 Jul 18; 13(2):343-51. PubMed ID: 8710373
    [Abstract] [Full Text] [Related]

  • 2. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase.
    Chung J, Grammer TC, Lemon KP, Kazlauskas A, Blenis J.
    Nature; 1994 Jul 07; 370(6484):71-5. PubMed ID: 8015612
    [Abstract] [Full Text] [Related]

  • 3. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.
    Minshall C, Arkins S, Freund GG, Kelley KW.
    J Immunol; 1996 Feb 01; 156(3):939-47. PubMed ID: 8558020
    [Abstract] [Full Text] [Related]

  • 4. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G, Sailaja D.
    Invest Ophthalmol Vis Sci; 2004 Oct 01; 45(10):3577-88. PubMed ID: 15452065
    [Abstract] [Full Text] [Related]

  • 5. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J, Adam RM, Santiestevan E, Freeman MR.
    Cancer Res; 1999 Jun 15; 59(12):2891-7. PubMed ID: 10383151
    [Abstract] [Full Text] [Related]

  • 6. M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways.
    Leloup C, Michaelson DM, Fisher A, Hartmann T, Beyreuther K, Stein R.
    Cell Death Differ; 2000 Sep 15; 7(9):825-33. PubMed ID: 11042677
    [Abstract] [Full Text] [Related]

  • 7. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
    Minshall C, Arkins S, Dantzer R, Freund GG, Kelley KW.
    J Immunol; 1999 Apr 15; 162(8):4542-9. PubMed ID: 10201993
    [Abstract] [Full Text] [Related]

  • 8. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.
    Altiok N, Altiok S, Changeux JP.
    EMBO J; 1997 Feb 17; 16(4):717-25. PubMed ID: 9049301
    [Abstract] [Full Text] [Related]

  • 9. Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin.
    Coulonval K, Vandeput F, Stein RC, Kozma SC, Lamy F, Dumont JE.
    Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):351-8. PubMed ID: 10816429
    [Abstract] [Full Text] [Related]

  • 10. Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway.
    Comalada M, Xaus J, Sánchez E, Valledor AF, Celada A.
    Eur J Immunol; 2004 Aug 01; 34(8):2257-67. PubMed ID: 15259023
    [Abstract] [Full Text] [Related]

  • 11. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.
    Monfar M, Lemon KP, Grammer TC, Cheatham L, Chung J, Vlahos CJ, Blenis J.
    Mol Cell Biol; 1995 Jan 01; 15(1):326-37. PubMed ID: 7528328
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways.
    Párrizas M, Saltiel AR, LeRoith D.
    J Biol Chem; 1997 Jan 03; 272(1):154-61. PubMed ID: 8995241
    [Abstract] [Full Text] [Related]

  • 13. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.
    Chou MM, Blenis J.
    Cell; 1996 May 17; 85(4):573-83. PubMed ID: 8653792
    [Abstract] [Full Text] [Related]

  • 14. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage.
    Price BD, Youmell MB.
    Cancer Res; 1996 Jan 15; 56(2):246-50. PubMed ID: 8542574
    [Abstract] [Full Text] [Related]

  • 15. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts.
    Goruppi S, Ruaro E, Varnum B, Schneider C.
    Mol Cell Biol; 1997 Aug 15; 17(8):4442-53. PubMed ID: 9234702
    [Abstract] [Full Text] [Related]

  • 16. Effects of wortmannin analogs on bone in vitro and in vivo.
    Sato M, Bryant HU, Dodge JA, Davis H, Matter WF, Vlahos CJ.
    J Pharmacol Exp Ther; 1996 Apr 15; 277(1):543-50. PubMed ID: 8613966
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phosphatidylinositol 3'-kinase, but not p70 ribosomal S6 kinase, is involved in membrane protein recycling: wortmannin inhibits glucose transport and downregulates cell-surface transferrin receptor numbers independently of any effect on fluid-phase endocytosis in fibroblasts.
    Jess TJ, Belham CM, Thomson FJ, Scott PH, Plevin RJ, Gould GW.
    Cell Signal; 1996 Jun 15; 8(4):297-304. PubMed ID: 8842531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.